Ligand validation:6SU3

LFA: EICOSANE

LFA is a Ligand Of Interest in 6SU3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	60%	0.6
6SU3_LFA_A_805	61%	99%	0.095	0.927	0.09	0.15	-	-	0	75%	0.75
6SU3_LFA_X_305	58%	99%	0.101	0.915	0.13	0.11	-	-	1	80%	0.8
6SU3_LFA_A_806	53%	99%	0.114	0.921	0.1	0.11	-	-	0	75%	0.75
6SU3_LFA_X_307	50%	98%	0.097	0.898	0.13	0.16	-	-	0	70%	0.7
6SU3_LFA_A_814	48%	98%	0.118	0.943	0.17	0.09	-	-	0	55%	0.55
6SU3_LFA_X_313	40%	99%	0.141	0.941	0.11	0.1	-	-	9	50%	0.5
6SU3_LFA_A_811	37%	100%	0.141	0.92	0.1	0.09	-	-	10	55%	0.55
6SU3_LFA_A_816	34%	97%	0.112	0.904	0.14	0.16	-	-	0	40%	0.4
6SU3_LFA_A_807	32%	99%	0.155	0.918	0.11	0.13	-	-	2	50%	0.5
6SU3_LFA_A_810	27%	98%	0.149	0.915	0.15	0.13	-	-	0	35%	0.35
6SU3_LFA_X_306	27%	100%	0.146	0.845	0.1	0.08	-	-	2	70%	0.7
6SU3_LFA_X_311	25%	98%	0.167	0.898	0.18	0.09	-	-	0	45%	0.45
6SU3_LFA_X_312	23%	96%	0.149	0.86	0.12	0.25	-	-	0	50%	0.5
6SU3_LFA_A_808	21%	99%	0.138	0.765	0.12	0.11	-	-	0	90%	0.9
6SU3_LFA_A_813	20%	96%	0.166	0.811	0.22	0.13	-	-	0	75%	0.75
6SU3_LFA_X_315	19%	97%	0.208	0.828	0.2	0.11	-	-	8	85%	0.85
6SU3_LFA_A_812	18%	100%	0.217	0.865	0.11	0.08	-	-	12	65%	0.65
6SU3_LFA_X_308	17%	100%	0.179	0.813	0.13	0.06	-	-	0	70%	0.7
6SU3_LFA_A_815	17%	99%	0.156	0.848	0.12	0.08	-	-	0	35%	0.35
6SU3_LFA_A_809	15%	99%	0.161	0.782	0.11	0.13	-	-	0	65%	0.65
6SU3_LFA_X_314	13%	98%	0.225	0.883	0.14	0.14	-	-	1	35%	0.35
6SU3_LFA_A_817	12%	99%	0.139	0.788	0.17	0.05	-	-	0	35%	0.35
6SU3_LFA_X_309	10%	99%	0.213	0.742	0.11	0.11	-	-	1	85%	0.85
6SU3_LFA_X_310	9%	98%	0.151	0.747	0.17	0.09	-	-	0	40%	0.4
6SU3_LFA_X_316	8%	100%	0.183	0.749	0.09	0.09	-	-	3	45%	0.45
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	70%	0.7
7Z09_LFA_A_801	40%	76%	0.087	0.914	0.37	0.58	-	-	1	35%	0.35

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

6SU3

LFA: EICOSANE

LFA is a Ligand Of Interest in 6SU3 designated by the RCSB